Innovative Lymph Node on a Chip Enhances Immune System Research and Precision Medicine
Researchers have developed a bioengineered lymph node-on-a-chip that replicates human immune functions, advancing research in disease, vaccine development, and personalized medicine.
Scientists at the Fralin Biomedical Research Institute at Virginia Tech have developed a groundbreaking bioengineered model mimicking the supportive tissue within human lymph nodes. This 'lymph node-on-a-chip' recreates essential features such as fluid flow and cellular interactions, offering a sophisticated platform to study immune responses outside the human body. By collaborating with researchers at the University of Virginia, the team aims to deepen understanding of immune functions and disease progression.
Lymph nodes play a crucial role in the immune system, filtering lymph fluid and orchestrating immune responses. Traditional models often rely on animal testing, which can be costly, less accurate, and ethically complex. The new engineered model utilizes human tissue, potentially providing more precise insights into human health and disease.
This innovative approach enables scientists to study how immune cells, particularly T cells, move and behave within the lymphatic system under various conditions, including inflammation. Notably, during inflammatory states, fluid flow within lymph nodes increases, influencing immune cell behavior—a phenomenon accurately reproduced by the model.
The research explores the potential of this lymph node-on-a-chip for several critical applications, including cancer metastasis, autoimmune disorders, vaccine testing, and viral infections. For example, since lymph nodes are common sites for tumor spread, understanding their microenvironment can inform better treatments. Additionally, the model could facilitate personalized therapies by testing how individual patients' tissues respond to different treatments.
Professor Jennifer Munson, the study's lead author, emphasizes that considering fluid dynamics is vital in modeling immune environments. The model's development was partly driven by a challenge prize aimed at advancing alternative biomedical research methods, moving beyond conventional animal models.
This engineered tissue platform marks a significant step toward more ethical, cost-effective, and human-relevant research, promising to accelerate discoveries in immune-related diseases and improve preclinical drug screening processes.
Source: https://medicalxpress.com/news/2025-06-lymph-node-chip-immune-precision.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Discovery of a Key Chemical that Enhances Esophageal and Upper Stomach Muscle Movement
A groundbreaking study reveals how the bodily chemical PAF stimulates muscle contractions in the esophagus and upper stomach, offering new insights into digestive and allergic conditions.
Vaginal Estrogen Tablets Found Safe for Postmenopausal Women After Stroke
New research suggests that vaginal estrogen tablets are safe for postmenopausal women with a history of stroke, showing no increased risk of recurrent ischemic strokes. This offers a promising option for managing menopausal symptoms without elevating stroke risk.
Understanding Post-Intensive Care Syndrome and Its Long-Term Impact
Research reveals that over half of ICU survivors experience lasting cognitive, physical, and psychological impairments, with key risk factors aiding early detection and intervention efforts.
FDA Takes Action Against Misleading DTC Drug Advertisements with Cease-and-Desist Orders
The FDA is stepping up efforts against misleading direct-to-consumer drug advertisements by issuing 100 cease-and-desist orders to ensure accurate and transparent pharmaceutical marketing.